Application of liposomal technologies for delivery of platinum analogs in oncology

References

• KellandLThe resurgence of platinum-based cancer chemotherapyNat Rev Cancer20077857358417625587
   PubMed Web of Science ®Google Scholar
• RosenbergBVan CampLKrigasTInhibition of cell division in Escherichia coli by electrolysis products from a platinum electrodeNature1965205497269869914287410
   PubMed Web of Science ®Google Scholar
• EinhornLHTreatment of testicular cancer: a new and improved modelJ Clin Oncol1990811177717811700077
   PubMed Web of Science ®Google Scholar
• LebwohlDCanettaRClinical development of platinum complexes in cancer therapy: an historical perspective and an updateEur J Cancer19983410152215349893623
   PubMed Web of Science ®Google Scholar
• WongEGiandomenicoCMCurrent status of platinum-based antitumor drugsChem Rev19999992451246611749486
   PubMed Web of Science ®Google Scholar
• JungYLippardSJDirect cellular responses to platinum-induced DNA damageChem Rev200710751387140717455916
   PubMed Web of Science ®Google Scholar
• WelshCDayRMcGurkCMastersJRWWoodRDKöberleBReduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell linesInt J Cancer2004110335236115095299
   PubMed Web of Science ®Google Scholar
• KöberleBMastersJRWHartleyJAWoodRDDefective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumoursCurr Biol19999527327810074455
   PubMed Web of Science ®Google Scholar
• WangDLippardSJCellular processing of platinum anticancer drugsNat Rev Drug Discov20054430732015789122
   PubMed Web of Science ®Google Scholar
• AmptoulachSTsavarisNNeurotoxicity caused by the treatment with platinum analoguesChemother Res Pract201120115
   Google Scholar
• BarabasKMilnerRLurieDAdinCCisplatin: a review of toxicities and therapeutic applicationsVet Comp Oncol20086111819178659
   PubMed Web of Science ®Google Scholar
• BoulikasTPantosABellisEChristofisPDesigning platinum compounds in cancer: structures and mechanismsCancer Ther20075537583
   Google Scholar
• CalvertAHarlandSNewellDEarly clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum IICancer Chemother Pharmacol1982931401476761010
   PubMed Web of Science ®Google Scholar
• WangXGuoZTargeting and delivery of platinum-based anticancer drugsChem Soc Rev201342120222423042411
   PubMed Web of Science ®Google Scholar
• WheateNJWalkerSCraigGEOunRThe status of platinum anticancer drugs in the clinic and in clinical trialsDalton Trans201039358113812720593091
   PubMed Web of Science ®Google Scholar
• MaedaHSawaTKonnoTMechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCSJ Control Release2001741–3476111489482
   PubMed Web of Science ®Google Scholar
• JainRKStylianopoulosTDelivering nanomedicine to solid tumorsNat Rev Clin Oncol201071165366420838415
   PubMed Web of Science ®Google Scholar
• MattheolabakisGRigasBConstantinidesPPNanodelivery strategies in cancer chemotherapy: biological rationale and pharmaceutical perspectivesNanomedicine (Lond)20127101577159023148540
   PubMed Web of Science ®Google Scholar
• MaedaHMatsumuraYEPR effect based drug design and clinical outlook for enhanced cancer chemotherapyAdv Drug Deliv Rev201163312913020457195
   PubMed Web of Science ®Google Scholar
• BanghamADStandishMMWatkinsJCDiffusion of univalent ions across the lamellae of swollen phospholipidsJ Mol Biol19651312382525859039
   PubMed Web of Science ®Google Scholar
• GregoriadisGSwainCPWillsEJTavillASDrug-carrier potentialof lipsomes in cancer chemotherapyLancet19743037870131313164134296
   PubMed Web of Science ®Google Scholar
• AkbarzadehARezaei-SadabadyRDavaranSLiposome: classification, preparation, and applicationsNanoscale Res Lett20138110223432972
   PubMed Web of Science ®Google Scholar
• KrasniciSWernerAEichhornMEEffect of the surface charge of liposomes on their uptake by angiogenic tumor vesselsInt J Cancer2003105456156712712451
   PubMed Web of Science ®Google Scholar
• TorchilinVPRecent advances with liposomes as pharmaceutical carriersNat Rev Drug Discov20054214516015688077
   PubMed Web of Science ®Google Scholar
• HaranGCohenRBarLKBarenholzYTransmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak basesBiochim Biophys Acta1993115122012158373796
   PubMed Web of Science ®Google Scholar
• BolotinEMCohenRBarLKAmmonium sulfate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandoliposomesJ Liposome Res199441455479
   Google Scholar
• MayerLDTaiLCLBallyMBMitilenesGNGinsbergRSCullisPRCharacterization of liposomal systems containing doxorubicin entrapped in response to pH gradientsBiochim Biophys Acta1990102521431512364073
   PubMed Web of Science ®Google Scholar
• OlsonFHuntCASzokaFCVailWJPapahadjopoulosDPreparation of liposomes of defined size distribution by extrusion through polycarbonate membranesBiochim Biophys Acta1979557192395096
   PubMed Web of Science ®Google Scholar
• KlibanovALMaruyamaKTorchilinVPHuangLAmphipathic polyethyleneglycols effectively prolong the circulation time of liposomesFEBS Lett199026812352372384160
   PubMed Web of Science ®Google Scholar
• PapahadjopoulosDAllenTMGabizonASterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacyProc Natl Acad Sci U S A1991882411460114641763060
   PubMed Web of Science ®Google Scholar
• BibiSLattmannEMohammedARPerrieYTrigger release liposome systems: local and remote controlled delivery?J Microencapsul201129326227622208705
   PubMed Web of Science ®Google Scholar
• DavidsenJJørgensenKAndresenTLMouritsenOGSecreted phospholipase A2 as a new enzymatic trigger mechanism for localised liposomal drug release and absorption in diseased tissueBiochim Biophys Acta2003160919510112507763
   PubMed Web of Science ®Google Scholar
• HuangS-LMacDonaldRCAcoustically active liposomes for drug encapsulation and ultrasound-triggered releaseBiochim Biophys Acta200416651–213414115471579
   PubMed Web of Science ®Google Scholar
• SmithBLyakhovILoomisKHyperthermia-triggered intracellular delivery of anticancer agent to HER2+ cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2+ affisomes)J Control Release2011153218719421501640
   PubMed Web of Science ®Google Scholar
• AhmadILongeneckerMSamuelJAllenTMAntibody-targeted delivery of doxorubicin entrapped in sterically stabilized liposomes can eradicate lung cancer in miceCancer Res1993537148414888453612
   PubMed Web of Science ®Google Scholar
• SapraPAllenTMInternalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugsCancer Res200262247190719412499256
   PubMed Web of Science ®Google Scholar
• AllenTMMoaseEHTherapeutic opportunities for targeted liposomal drug deliveryAdv Drug Deliv Rev1996212117133
   Web of Science ®Google Scholar
• GabizonACataneRUzielyBProlonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomesCancer Res19945449879928313389
   PubMed Web of Science ®Google Scholar
• SafraTMuggiaFJeffersSPegylated liposomal doxorubicin (Doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2Ann Oncol20001181029103311038041
   PubMed Web of Science ®Google Scholar
• LorussoDDi StefanoACaroneVFagottiAPiscontiSScambiaGPEGylated liposomal doxorubicin-related palmar-plantar erythrodysesthesia (‘hand-foot’ syndrome)Ann Oncol20071871159116417229768
   PubMed Web of Science ®Google Scholar
• BarenholzYDoxil® – the first FDA-approved nano-drug: lessons learnedJ Control Release2012160211713422484195
   PubMed Web of Science ®Google Scholar
• AllenTMCullisPRLiposomal drug delivery systems: from concept to clinical applicationsAdv Drug Deliv Rev2013651364823036225
   PubMed Web of Science ®Google Scholar
• VadieiKSiddikZKhokharAAl-BakerSSampedroFPerez-SolerRPharmacokinetics of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) and cisplatin given i.v. and i.p. in the ratCancer Chemother Pharmacol19923053653691505075
   PubMed Web of Science ®Google Scholar
• KhokharARWrightKSiddikZHPerez-SolerROrgan distribution and tumor uptake of liposome entrapped cis-bis-neodecanoato trans-R, R-1,2 diaminocyclohexane platinum (II) administered intravenously and into the proper hepatic arteryCancer Chemother Pharmacol19882232232273409456
   PubMed Web of Science ®Google Scholar
• HanILingY-HAl-BakerSKhokharARPerez-SolerRCellular pharmacology of liposomal cis-bis-neodecanoato-trans-r,r-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cellsCancer Res19935320491349198402681
   PubMed Web of Science ®Google Scholar
• Perez-SolerRLautersztainJStephensLCWrightKKhokharARPreclinical toxicity and pharmacology of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II)Cancer Chemother Pharmacol1989241182720887
   PubMed Web of Science ®Google Scholar
• Perez-SolerRYangLYDrewinkoBLauterzstainJKhokharARIncreased cytotoxicity and reversal of resistance to cis-diamminedichloroplatinum(II) with entrapment of cis-bis-neodecanoato-trans-r,r-1,2-diaminocyclohexaneplatinum(II) in multilamellar lipid vesiclesCancer Res19884816450945123396003
   PubMed Web of Science ®Google Scholar
• Perez-SolerRKhokharARLopez-BeresteinGTreatment and prophylaxis of experimental liver metastases of M5076 reticulosarcoma with cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) encapsulated in multilamellar vesiclesCancer Res19874724 Part 1646264663315188
   PubMed Web of Science ®Google Scholar
• Perez-SolerRLopez-BeresteinGLautersztainJPhase I clinical and pharmacological study of liposome-entrapped cis-bis-neodecanoato-trans-R,R,-1,2-diaminocyclohexane platinum(II)Cancer Res19905014425442592364384
   PubMed Web of Science ®Google Scholar
• DragovichTMendelsonDKurtinSRichardsonKHoffDHoosAA Phase 2 trial of the liposomal DACH platinum L-NDDP in patients with therapy-refractory advanced colorectal cancerCancer Chemother Pharmacol200658675976416847673
   PubMed Web of Science ®Google Scholar
• MoriAWuS-PHanIKhokharAPerez-SolerRHuangLIn vivo antitumor activity of cis-bis-neodecanoato-trans-R,R-l,2-diaminocyclohexane platinum(II) formulated in long-circulating liposomesCancer Chemother Pharmacol19963754354448599866
   PubMed Web of Science ®Google Scholar
• NewmanMSColbernGTWorkingPKEngbersCAmanteaMAComparative pharmacokinetics, tissue distribution, and therapeutic effectiveness of cisplatin encapsulated in long-circulating, PEGylated liposomes (SPI-077) in tumor-bearing miceCancer Chemother Pharmacol1999431179923534
   PubMed Web of Science ®Google Scholar
• BandakSGorenDHorowitzATzemachDGabizonAPharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor modelsAnticancer Drugs1999101091192010630359
   PubMed Web of Science ®Google Scholar
• ZamboniWGervaisAEgorinMSystemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanomaCancer Chemother Pharmacol200453432933614673619
   PubMed Web of Science ®Google Scholar
• Meerum TerwogtJGroenewegenGPluimDPhase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatinCancer Chemother Pharmacol200249320121011935212
   PubMed Web of Science ®Google Scholar
• HarringtonKJLewanskiCRNorthcoteADPhase I-II study of PEGylated liposomal cisplatin (SPI-077 TM) in patients with inoperable head and neck cancerAnn Oncol200112449349611398881
   PubMed Web of Science ®Google Scholar
• WhiteSCLoriganPMargisonGPPhase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancerBr J Cancer200695782282816969346
   PubMed Web of Science ®Google Scholar
• SeetharamuNKimEHochsterHMartinFMuggiaFPhase II study of liposomal cisplatin (SPI-77) in platinum-sensitive recurrences of ovarian cancerAnticancer Res201030254154520332467
   PubMed Web of Science ®Google Scholar
• StathopoulosGPBoulikasTLipoplatin formulation review articleJ Drug Deliv2012201258136321904682
   PubMedGoogle Scholar
• VealGJGriffinMJPriceEA phase I study in paediatric patients to evaluate the safety and pharmacokinetics of SPI-77, a liposome encapsulated formulation of cisplatinBr J Cancer20018481029103511308249
   PubMed Web of Science ®Google Scholar
• BoulikasTLow toxicity and anticancer activity of a novel liposomal cisplatin (Lipoplatin) in mouse xenograftsOncol Rep200412131215201951
   PubMed Web of Science ®Google Scholar
• DevarajanPTarabishiRMishraJLow renal toxicity of lipoplatin compared to cisplatin in animalsAnticancer Res20042442193220015330160
   PubMed Web of Science ®Google Scholar
• MarrAKKurzmanIDVailDMPreclinical evaluation of a liposome-encapsulated formulation of cisplatin in clinically normal dogsAm J Vet Res200465111474147815566083
   PubMed Web of Science ®Google Scholar
• BoulikasTClinical overview on Lipoplatin™: a successful liposomal formulation of cisplatinExpert Opin Investig Drugs200918811971218
   PubMed Web of Science ®Google Scholar
• BoulikasTStathopoulosGPVolakakisNVougioukaMSystemic Lipoplatin infusion results in preferential tumor uptake in human studiesAnticancer Res20052543031303916080562
   PubMed Web of Science ®Google Scholar
• StathopoulosGPAntoniouDDimitroulisJStathopoulosJMarosisKMichalopoulouPComparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancerCancer Chemother Pharmacol201168494595021301848
   PubMed Web of Science ®Google Scholar
• StathopoulosGPBoulikasTKourvetarisAStathopoulosJLiposomal oxaliplatin in the treatment of advanced cancer: a Phase I studyAnticancer Res2006262B1489149316619562
   PubMed Web of Science ®Google Scholar
• de JongeMJSlingerlandMLoosWJEarly cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulationEur J Cancer201046163016302120801016
   PubMed Web of Science ®Google Scholar
• BurgerKNStaffhorstRWde VijlderHCNanocapsules: lipid-coated aggregates of cisplatin with high cytotoxicityNat Med200281818411786911
   PubMed Web of Science ®Google Scholar
• KhiatiSLuvinoDOumzilKChauffertBCamploMBarthélémyPNucleoside-lipid-based nanoparticles for cisplatin deliveryACS Nano20115118649865521961944
   PubMed Web of Science ®Google Scholar
• AryalSHuC-MJZhangLSynthesis of Ptsome: a platinum-based liposome-like nanostructureChem Commun (Camb)201248202630263222286522
   PubMed Web of Science ®Google Scholar
• LeeCMTanakaTMuraiTNovel chondroitin sulfate-binding cationic liposomes loaded with cisplatin efficiently suppress the local growth and liver metastasis of tumor cells in vivoCancer Res200262154282428812154030
   PubMed Web of Science ®Google Scholar
• SuzukiRTakizawaTKuwataYEffective anti-tumor activity of oxaliplatin encapsulated in transferrin PEG-liposomeInt J Pharm20083461–214315017640835
   PubMed Web of Science ®Google Scholar
• RieterWJTaylorKMAnHLinWLinWNanoscale metal-organic frameworks as potential multimodal contrast enhancing agentsJ Am Chem Soc2006128289024902516834362
   PubMed Web of Science ®Google Scholar
• RieterWJPottKMTaylorKMLinWNanoscale coordination polymers for platinum-based anticancer drug deliveryJ Am Chem Soc200813035115841158518686947
   PubMed Web of Science ®Google Scholar
• TaylorKMJinALinWSurfactant-assisted synthesis of nanoscale gadolinium metal-organic frameworks for potential multimodal imagingAngew Chem Int Ed2008474077227725
   PubMed Web of Science ®Google Scholar
• LiuDHuxfordRCLinWPhosphorescent nanoscale coordination polymers as contrast agents for optical imagingAngew Chem Int Ed2011501636963700
   Web of Science ®Google Scholar
• HuxfordRCdeKrafftKEBoyleWSLiuDLinWLipid-coated nanoscale coordination polymers for targeted delivery of antifolates to cancer cellsChem Sci201231198204
   Web of Science ®Google Scholar
• LiuDKramerSAHuxford-PhillipsRCWangSDella RoccaJLinWCoercing bisphosphonates to kill cancer cells with nanoscale coordination polymersChem Commun (Camb)201248212668267022428170
   PubMed Web of Science ®Google Scholar
• deKrafftKEBoyleWSBurkLMZhouOZLinWZr- and Hf-based nanoscale metal-organic frameworks as contrast agents for computed tomographyJ Mater Chem20122235181391814423049169
   PubMed Web of Science ®Google Scholar
• Huxford-PhillipsRCRussellSRLiuDLipid-coated nanoscale coordination polymers for targeted cisplatin deliveryRSC Adv201331443814443
   PubMed Web of Science ®Google Scholar
• BatistGRamakrishnanGRaoCSReduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancerJ Clin Oncol20011951444145411230490
   PubMed Web of Science ®Google Scholar
• BerryGBillinghamMAldermanEThe use of cardiac biopsy to demonstrate reduced cardiotoxicity in AIDS Kaposi’s sarcoma patients treated with pegylated liposomal doxorubicinAnn Oncol1998977117169739435
   PubMed Web of Science ®Google Scholar
• LeeRJLowPSDelivery of liposomes into cultured KB cells via folate receptor-mediated endocytosisJ Biol Chem19942695319832048106354
   PubMed Web of Science ®Google Scholar
• BanerjeeGNandiGMahatoSBPakrashiABasuMKDrug delivery system: targeting of pentamidines to specific sites using sugar grafted liposomesJ Antimicrob Chemother19963811451508858467
   PubMed Web of Science ®Google Scholar
• Lopes de MenezesDEPilarskiLMAllenTMIn vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphomaCancer Res19985815332033309699662
   PubMed Web of Science ®Google Scholar
• KirpotinDParkJWHongKSterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitroBiochemistry199736166758993319
   PubMed Web of Science ®Google Scholar
• AllenTMMehraTHansenCChinYCStealth liposomes: an improved sustained release system for 1-β-d-arabinofuranosylcytosineCancer Res1992529243124391568213
   PubMed Web of Science ®Google Scholar
• BallyMBLimHCullisPRMayerLDControlling the drug delivery attributes of lipid-based drug formulationsJ Liposome Res199883299335
   Web of Science ®Google Scholar